Heidelberg Pharma AG (HPHA) — Net Asset Quality Index
Heidelberg Pharma AG (HPHA) has a Net Asset Quality Index of 29.7% as of May 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €62.45 Million minus total liabilities of €43.94 Million yields net assets of €18.52 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read HPHA liabilities breakdown for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Heidelberg Pharma AG Net Asset Quality Index Over Time (2016–2024)
This chart shows how Heidelberg Pharma AG's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of May 2025, the index stands at 29.7%, representing net assets of €18.52 Million against total assets of €62.45 Million EUR. For live market cap and overall valuation, see Heidelberg Pharma AG stock valuation.
Annual Net Asset Quality Index for Heidelberg Pharma AG (2016–2024)
The table below presents the year-by-year Net Asset Quality Index for Heidelberg Pharma AG from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Heidelberg Pharma AG PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 50.8% | €30.87 Million | €60.72 Million | €29.85 Million | ▼ -19.3 pp |
| 2023 | 70.1% | €49.34 Million | €70.35 Million | €21.01 Million | ▲ +3.9 pp |
| 2022 | 66.3% | €66.64 Million | €100.58 Million | €33.94 Million | ▲ +35.4 pp |
| 2021 | 30.8% | €6.70 Million | €21.73 Million | €15.03 Million | ▼ -34.9 pp |
| 2020 | 65.7% | €12.88 Million | €19.61 Million | €6.73 Million | ▼ -5.2 pp |
| 2019 | 70.9% | €16.29 Million | €22.99 Million | €6.70 Million | ▼ -12.1 pp |
| 2018 | 83.0% | €25.89 Million | €31.19 Million | €5.31 Million | ▼ -6.2 pp |
| 2017 | 89.2% | €37.02 Million | €41.49 Million | €4.47 Million | ▲ +25.2 pp |
| 2016 | 64.0% | €9.76 Million | €15.24 Million | €5.49 Million | — |